Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EU and Japan reinforce their collaboration on inspections of medicine manufacturers 18 July 2018Press releaseCorporateCompliance and inspections Update on review of valsartan medicines following detection of impurity in active substance: assessing potential impact on patients is priority 17 July 2018Press releaseHuman EMA's proactive publication of clinical data a success 16 July 2018NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 July 2018 13 July 2018NewsHumanPharmacovigilance EMA's Pharmacovigilance and Risk Assessment Committee (PRAC) elects new Chair 11 July 2018NewsCorporatePharmacovigilance EMA identifies gaps in industry preparedness for Brexit 10 July 2018Press releaseCorporateBrexit EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity: some valsartan medicines being recalled across the EU 5 July 2018Press releaseHuman First two CAR-T cell medicines recommended for approval in the European Union 29 June 2018Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018 29 June 2018NewsHuman Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients 29 June 2018Press releaseHuman 1 … 114 115 116 117 118 Page 118 of 380 119 120 121 122 … 380
EU and Japan reinforce their collaboration on inspections of medicine manufacturers 18 July 2018Press releaseCorporateCompliance and inspections
Update on review of valsartan medicines following detection of impurity in active substance: assessing potential impact on patients is priority 17 July 2018Press releaseHuman
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 July 2018 13 July 2018NewsHumanPharmacovigilance
EMA's Pharmacovigilance and Risk Assessment Committee (PRAC) elects new Chair 11 July 2018NewsCorporatePharmacovigilance
EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity: some valsartan medicines being recalled across the EU 5 July 2018Press releaseHuman
First two CAR-T cell medicines recommended for approval in the European Union 29 June 2018Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018 29 June 2018NewsHuman
Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients 29 June 2018Press releaseHuman